| |
|
|
| Name: |
venBio Select Advisor LLC |
| City: |
San Francisco |
| State: |
CA |
| Zip: |
94158 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
21 |
|
View All Holdings |
Currently
Viewing:
Increased Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
UTHR |
United Therapeutics Corp |
2 |
- |
$264.27 |
$628,641,000 |
2,858,888 |
8.68% |
-15,653,000 |
6,388 |
6.049 |
Drug Manufacturers - ... |
|
|
ASND |
Ascendis Pharma AS |
3 |
- |
$133.46 |
$473,012,000 |
3,755,555 |
6.53% |
129,353,000 |
85,555 |
5.811 |
N/A |
|
|
ARGX |
Argenx Se |
4 |
- |
$374.63 |
$469,666,000 |
1,234,567 |
6.49% |
-21,964,000 |
234,567 |
2.626 |
N/A |
|
|
MDGL |
Madrigal Pharmaceuticals Inc |
5 |
- |
$205.25 |
$437,051,000 |
1,888,888 |
6.04% |
209,959,000 |
333,888 |
11.393 |
Diagnostic Substances |
|
|
SRPT |
Sarepta Therapeutics Inc |
6 |
- |
$131.82 |
$418,935,000 |
4,344,444 |
5.79% |
-68,976,000 |
319,444 |
5.16 |
Drug Manufacturers - ... |
|
|
BMRN |
Biomarin Pharmaceutical Inc |
7 |
- |
$88.63 |
$414,606,000 |
4,300,000 |
5.73% |
73,958,000 |
450,000 |
2.283 |
Drug Manufacturers - ... |
|
|
CERE |
Cerevel Therapeutics Holdin... |
10 |
- |
$42.19 |
$320,356,000 |
7,555,555 |
4.42% |
299,496,000 |
6,600,000 |
4.833 |
N/A |
|
|
CBAY |
Cymabay Therapeutics, Inc. |
13 |
- |
$32.48 |
$262,444,000 |
11,111,111 |
3.63% |
108,871,000 |
811,111 |
11.729 |
N/A |
|
|
XENE |
Xenon Pharmaceuticals Inc. |
14 |
- |
$0.00 |
$261,007,000 |
5,666,666 |
3.61% |
93,623,000 |
766,666 |
9.061 |
N/A |
|
|
ALNY |
Alnylam Pharmaceuticals Inc |
15 |
- |
$150.47 |
$212,678,000 |
1,111,111 |
2.94% |
33,610,000 |
100,000 |
0.903 |
Biotechnology |
|
|
MLTX |
Multisys Language Solutions... |
17 |
- |
$0.00 |
$155,806,000 |
2,580,000 |
2.15% |
41,806,000 |
580,001 |
6.278 |
N/A |
|
|
GPCR |
Structure Therapeutics Inc. |
19 |
- |
$35.82 |
$95,107,000 |
2,333,333 |
1.31% |
44,687,000 |
1,333,333 |
6.097 |
N/A |
|
|
SNDX |
Syndax Pharmaceuticals Inc |
20 |
- |
$21.75 |
$91,242,000 |
4,222,222 |
1.26% |
54,135,000 |
1,666,667 |
5.5 |
N/A |
|
|
BCRX |
Biocryst Pharmaceuticals Inc |
21 |
- |
$5.32 |
$78,170,000 |
13,050,000 |
1.08% |
-3,604,000 |
1,500,000 |
7.391 |
Biotechnology |
|
|
AGLE |
Aeglea Biotherapeutics, Inc. |
25 |
- |
$0.60 |
$39,578,000 |
1,839,138 |
0.55% |
39,438,000 |
1,827,680 |
3.007 |
N/A |
|
|
RCKT |
Rocket Pharmaceuticals |
27 |
- |
$22.72 |
$37,789,000 |
1,260,900 |
0.52% |
12,176,000 |
10,900 |
1.602 |
N/A |
|
|
ARWR |
Arrowhead Pharmaceuticals Inc |
28 |
- |
$22.08 |
$34,578,000 |
1,130,000 |
0.48% |
19,396,000 |
565,000 |
1.105 |
Business Services |
|
|
VRCA |
Verrica Pharmaceuticals Inc. |
32 |
- |
$8.00 |
$29,280,000 |
3,999,999 |
0.4% |
17,803,000 |
1,045,935 |
15.564 |
N/A |
|
|
MRUS |
Merus Nv |
35 |
- |
$44.52 |
$24,444,000 |
888,888 |
0.34% |
13,964,000 |
444,444 |
2.083 |
N/A |
|
|
TRML |
Tourmaline Bio |
36 |
- |
$0.00 |
$22,735,000 |
868,407 |
0.31% |
21,330,000 |
368,407 |
2.102 |
N/A |
|
|
TSHA |
Taysha Gene Therapies, Inc. |
41 |
- |
$0.00 |
$7,709,000 |
4,355,555 |
0.11% |
-4,694,000 |
430,555 |
11.775 |
N/A |
|
